You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Details for New Drug Application (NDA): 021445


✉ Email this page to a colleague

« Back to Dashboard


NDA 021445 describes ZETIA, which is a drug marketed by Organon and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the ZETIA profile page.

The generic ingredient in ZETIA is ezetimibe. There are twenty-four drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ezetimibe profile page.
Summary for 021445
Tradename:ZETIA
Applicant:Organon
Ingredient:ezetimibe
Patents:1
Pharmacology for NDA: 021445
Physiological EffectDecreased Cholesterol Absorption
Medical Subject Heading (MeSH) Categories for 021445
Suppliers and Packaging for NDA: 021445
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZETIA ezetimibe TABLET;ORAL 021445 NDA Organon LLC 78206-178 78206-178-01 30 TABLET in 1 BOTTLE (78206-178-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Oct 25, 2002TE:ABRLD:Yes
Patent:⤷  Sign UpPatent Expiration:Apr 30, 2026Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 021445

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon ZETIA ezetimibe TABLET;ORAL 021445-001 Oct 25, 2002 ⤷  Sign Up ⤷  Sign Up
Organon ZETIA ezetimibe TABLET;ORAL 021445-001 Oct 25, 2002 ⤷  Sign Up ⤷  Sign Up
Organon ZETIA ezetimibe TABLET;ORAL 021445-001 Oct 25, 2002 ⤷  Sign Up ⤷  Sign Up
Organon ZETIA ezetimibe TABLET;ORAL 021445-001 Oct 25, 2002 ⤷  Sign Up ⤷  Sign Up
Organon ZETIA ezetimibe TABLET;ORAL 021445-001 Oct 25, 2002 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.